Drug · DIN 02457954
MINT-LEVOCARB
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 12, 2026; first marketed November 3, 2016.
- Drug Identification Number (DIN)
- 02457954
- Company (DIN owner)
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Levodopa and decarboxylase inhibitor N04BA02
- Class
- Human
- Record last updated
- July 13, 2026
Active ingredients
As listed in the Drug Product Database.
Notices of Compliance
Health Canada approvals that name this DIN.
- September 23, 2016: NOC 18513Abbreviated New Drug Submission (ANDS)
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “mint-levocarb”. A notice may cover another product or only some lots: read it to see what it covers.
- MINT-LEVOCARB (2017-12-13)December 13, 2017 · Drugs · Product safety · Type III
Other DINs named MINT-LEVOCARB
- DIN 02457962 · Marketed
- DIN 02457970 · Dormant